Recommendations for clinical decision-making when offering exoskeletons for community use in individuals with spinal cord injury
Approved in 2014 by the Food and Drug Administration (FDA) for use with a trained companion, personal powered exoskeletons (PPE) for individuals with spinal cord injury (SCI) provide an opportunity for the appropriate candidate to ambulate in their home and community. As an adjunct to wheeled mobili...
Saved in:
Main Authors: | Derrick Onate (Author), Cassandra Hogan (Author), Kathryn Fitzgerald (Author), Kevin T. White (Author), Keith Tansey (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
by: Apostolos Zarros, et al.
Published: (2019) -
Soleus H and Lower Limb Posterior Root Muscle Reflexes During Stepping After Incomplete SCI
by: Keith E. Tansey, et al.
Published: (2022) -
The influence of walking in an exoskeleton on rehabilitation of patients with spinal cord injury consequences
by: M. A. Gvozdareva, et al.
Published: (2023) -
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
by: Fiona E McAlpine, et al.
Published: (2008) -
Exoskeleton Training and Trans-Spinal Stimulation for Physical Activity Enhancement After Spinal Cord Injury (EXTra-SCI): An Exploratory Study
by: Tommy W. Sutor, et al.
Published: (2022)